These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20485382)

  • 1. Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector.
    Becker PS; Taylor JA; Trobridge GD; Zhao X; Beard BC; Chien S; Adair J; Kohn DB; Wagner JE; Shimamura A; Kiem HP
    Gene Ther; 2010 Oct; 17(10):1244-52. PubMed ID: 20485382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice.
    Río P; Segovia JC; Hanenberg H; Casado JA; Martínez J; Göttsche K; Cheng NC; Van de Vrugt HJ; Arwert F; Joenje H; Bueren JA
    Blood; 2002 Sep; 100(6):2032-9. PubMed ID: 12200363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid lentiviral transduction preserves the engraftment potential of Fanca(-/-) hematopoietic stem cells.
    Müller LU; Milsom MD; Kim MO; Schambach A; Schuesler T; Williams DA
    Mol Ther; 2008 Jun; 16(6):1154-60. PubMed ID: 18398427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lentiviral-Mediated Gene Therapy in Fanconi Anemia-A Mice Reveals Long-Term Engraftment and Continuous Turnover of Corrected HSCs.
    Molina-Estevez FJ; Nowrouzi A; Lozano ML; Galy A; Charrier S; von Kalle C; Guenechea G; Bueren JA; Schmidt M
    Curr Gene Ther; 2015; 15(6):550-62. PubMed ID: 26415575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal conditioning in Fanconi anemia promotes multi-lineage marrow engraftment at 10-fold lower cell doses.
    Haworth KG; Ironside C; Ramirez MA; Weitz S; Beard BC; Schwartz JD; Adair JE; Kiem HP
    J Gene Med; 2018 Oct; 20(10-11):e3050. PubMed ID: 30129972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia.
    Río P; Navarro S; Wang W; Sánchez-Domínguez R; Pujol RM; Segovia JC; Bogliolo M; Merino E; Wu N; Salgado R; Lamana ML; Yañez RM; Casado JA; Giménez Y; Román-Rodríguez FJ; Álvarez L; Alberquilla O; Raimbault A; Guenechea G; Lozano ML; Cerrato L; Hernando M; Gálvez E; Hladun R; Giralt I; Barquinero J; Galy A; García de Andoín N; López R; Catalá A; Schwartz JD; Surrallés J; Soulier J; Schmidt M; Díaz de Heredia C; Sevilla J; Bueren JA
    Nat Med; 2019 Sep; 25(9):1396-1401. PubMed ID: 31501599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34
    Río P; Navarro S; Guenechea G; Sánchez-Domínguez R; Lamana ML; Yañez R; Casado JA; Mehta PA; Pujol MR; Surrallés J; Charrier S; Galy A; Segovia JC; Díaz de Heredia C; Sevilla J; Bueren JA
    Blood; 2017 Sep; 130(13):1535-1542. PubMed ID: 28801449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors.
    Galimi F; Noll M; Kanazawa Y; Lax T; Chen C; Grompe M; Verma IM
    Blood; 2002 Oct; 100(8):2732-6. PubMed ID: 12351379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.
    Yamada K; Olsen JC; Patel M; Rao KW; Walsh CE
    Mol Ther; 2001 Apr; 3(4):485-90. PubMed ID: 11319908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotype correction of Fanconi anemia group A hematopoietic stem cells using lentiviral vector.
    Yamada K; Ramezani A; Hawley RG; Ebell W; Arwert F; Arnold LW; Walsh CE
    Mol Ther; 2003 Oct; 8(4):600-10. PubMed ID: 14529833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic correction of Fanconi anemia cells in the murine bone marrow after carrier cell mediated delivery of lentiviral vector.
    Chakkaramakkil Verghese S; Goloviznina NA; Kurre P
    Stem Cell Res Ther; 2016 Nov; 7(1):170. PubMed ID: 27865213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC).
    Liu JM; Kim S; Read EJ; Futaki M; Dokal I; Carter CS; Leitman SF; Pensiero M; Young NS; Walsh CE
    Hum Gene Ther; 1999 Sep; 10(14):2337-46. PubMed ID: 10515453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II Gene Therapy Trial of Fanconi Anemia Patients with a New Orphan Drug Consisting of a Lentiviral Vector Carrying the FANCA Gene: A Coordinated International Action (EuroFancolen).
    Hum Gene Ther Clin Dev; 2015 Jun; 26(2):81-2. PubMed ID: 26086753
    [No Abstract]   [Full Text] [Related]  

  • 14. Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency.
    Verhoeyen E; Roman-Rodriguez FJ; Cosset FL; Levy C; Rio P
    Curr Gene Ther; 2017; 16(5):297-308. PubMed ID: 28067165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Numbers of long-term hematopoietic stem cells from bone marrow of fanca and fancc knockout mice can be greatly enhanced by their collection and processing in physioxia conditions.
    Broxmeyer HE; Capitano ML; Cooper S; Potchanant ES; Clapp DW
    Blood Cells Mol Dis; 2021 Feb; 86():102492. PubMed ID: 32896825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem Cell Genetic Therapy for Fanconi Anemia - A New Hope.
    Hanenberg H; Roellecke K; Wiek C
    Curr Gene Ther; 2017; 16(5):309-320. PubMed ID: 28067166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral-mediated genetic correction of hematopoietic and mesenchymal progenitor cells from Fanconi anemia patients.
    Jacome A; Navarro S; Río P; Yañez RM; González-Murillo A; Lozano ML; Lamana ML; Sevilla J; Olive T; Diaz-Heredia C; Badell I; Estella J; Madero L; Guenechea G; Casado J; Segovia JC; Bueren JA
    Mol Ther; 2009 Jun; 17(6):1083-92. PubMed ID: 19277017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo repopulation ability of genetically corrected bone marrow cells from Fanconi anemia patients.
    Cohen-Haguenauer O; Péault B; Bauche C; Daniel MT; Casal I; Levy V; Dausset J; Boiron M; Auclair C; Gluckman E; Marty M
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2340-5. PubMed ID: 16461901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of lentiviral vectors with optimized transcriptional activity for the gene therapy of patients with Fanconi anemia.
    González-Murillo A; Lozano ML; Alvarez L; Jacome A; Almarza E; Navarro S; Segovia JC; Hanenberg H; Guenechea G; Bueren JA; Río P
    Hum Gene Ther; 2010 May; 21(5):623-30. PubMed ID: 20001454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviral mediated gene transfer of the Fanconi anemia complementation group C gene to hematopoietic progenitors of group C patients.
    Liu JM; Young NS; Walsh CE; Cottler-Fox M; Carter C; Dunbar C; Barrett AJ; Emmons R
    Hum Gene Ther; 1997 Sep; 8(14):1715-30. PubMed ID: 9322874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.